跳到正文
原文
Endpoints News 生物医药· Max Bayer·· 7 天前AI 评分45

HHS 加大资金与研究支持 psychedelic 药物

HHS directs new funds, research for psychedelics work

AI 导读

HHS 宣布为 ibogaine 等 psychedelic 药物提供新资金与研究支持,响应特朗普春季发布的优先研究指令。

正文

Secretary of Health and Human Services Robert F. Kennedy Jr. testifies during a House Energy and Commerce Subcommittee hearing on the HHS budget for 2026, at the U.S. Capitol, in Washington, D.C., on Tuesday, June 24, 2025. (Graeme Sloan/Sipa USA)(Sipa via AP Images)

November 12, 2026 03:09 PM EST

HHS fun­nels fund­ing and re­search to­ward ibo­gaine and oth­er psy­che­delics, with Mark Cuban’s help

Fol­low­ing Pres­i­dent Don­ald Trump’s ex­ec­u­tive or­der in the spring to make psy­che­delics re­search a pri­or­i­ty, HHS on Thurs­day an­nounced a flur­ry of new fund­ing and …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Think we're worth reading - tell Google.

Confirm Endpoints as a trusted biopharma news source

Confirm on Google

ENDPOINTS CAREERS

来源:Endpoints News 生物医药 · endpoints.news